EVE Health Group (EVE) Stock Price, News & Analysis

Company Overview

Eve Health Group Limited, together with its subsidiaries, engages in the production and distribution of nutrition, health, and wellness products in Australia, New Zealand, the Asia Pacific, and North America. It provides organic tea tree oils; and distributes botanical oils, as well as supplies essential oils, hydrosols, extracts, carrier oils, and seed oils. The company also offers organic raw honey and raw honey probiotic concentrates; and contract manufacturing services. In addition, it offers medical nutrition solutions for chronic and lifestyle diseases, including Gluco Smooth for type 2 diabetes that reduces the post-meal blood sugar levels; and dietary interventions. The company was formerly known as EVE Investments Limited. Eve Health Group Limited was incorporated in 2003 and is based in Subiaco, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 3.21 million shs
• Average Volume: N/A
• Market Capitalization: A$5.27 million
• P/E Ratio: N/A
• Dividend Yield: 8.15%
• Price Target: N/A
• Consensus Rating: N/A

EVE Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of EVE Health Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that EVE Health Group investors own include Adelong Gold (DDD) and Hess (HES).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Consumer Defensive
• Industry: Packaged Foods
• Sub-Industry: N/A
• Current Symbol: ASX:EVE
• CIK: N/A
• Web: www.eveinvestments.com.au
• Phone: 61 8 6465 5500
• Fax: N/A
• Employees: 147,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$1.55 million
• Net Margins: -89.09%
• Pretax Margin: N/A
• Return on Equity: -111.83%
• Return on Assets: -29.61%

Debt

• Debt-to-Equity Ratio: 6.12
• Current Ratio: 1.94
• Quick Ratio: 1.72

Sales & Book Value

• Annual Sales: A$2.13 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 2.50
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 5,270,000,000
• Free Float: N/A
• Market Cap: A$5.27 million
• Optionable: Not Optionable
• Beta: 1.00